WO1997020048A3 - Modified SFV molecules which mediate adhesion between cells and uses thereof - Google Patents

Modified SFV molecules which mediate adhesion between cells and uses thereof Download PDF

Info

Publication number
WO1997020048A3
WO1997020048A3 PCT/US1996/019051 US9619051W WO9720048A3 WO 1997020048 A3 WO1997020048 A3 WO 1997020048A3 US 9619051 W US9619051 W US 9619051W WO 9720048 A3 WO9720048 A3 WO 9720048A3
Authority
WO
WIPO (PCT)
Prior art keywords
cells
sfv molecules
mediate adhesion
molecules
modified sfv
Prior art date
Application number
PCT/US1996/019051
Other languages
French (fr)
Other versions
WO1997020048A2 (en
Inventor
Jeffrey A Ledbetter
Martha Hayden
Perry Fell
Robert Mittler
Gosta Winberg
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of WO1997020048A2 publication Critical patent/WO1997020048A2/en
Publication of WO1997020048A3 publication Critical patent/WO1997020048A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70521—CD28, CD152
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70528—CD58
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The modified sFv molecules of the present invention stimulate adhesion between cells thereby enhancing the immune response against disease. These molecules generally comprise an antigen binding site of an antibody and at least a portion of a transmembrane domain of a cell surface receptor.
PCT/US1996/019051 1995-11-30 1996-11-27 Modified sfv molecules which mediate adhesion between cells and uses thereof WO1997020048A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US775595P 1995-11-30 1995-11-30
US60/007,755 1995-11-30

Publications (2)

Publication Number Publication Date
WO1997020048A2 WO1997020048A2 (en) 1997-06-05
WO1997020048A3 true WO1997020048A3 (en) 1997-09-25

Family

ID=21727962

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/019051 WO1997020048A2 (en) 1995-11-30 1996-11-27 Modified sfv molecules which mediate adhesion between cells and uses thereof

Country Status (1)

Country Link
WO (1) WO1997020048A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891432A (en) 1997-07-29 1999-04-06 The Immune Response Corporation Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same
US6416973B1 (en) 1997-08-01 2002-07-09 Schering Corporation Nucleic acids encoding mammalian cell membrane protein MDL-1
WO1999028349A2 (en) 1997-12-02 1999-06-10 Medarex, Inc. CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
DE10160248A1 (en) * 2001-12-07 2003-06-26 Alexander Cherkasky New fusion protein, useful for treating e.g. tumors, viral infections and autoimmune disease, comprises an Fc antibody region and at least one other domain and improves the response of antigen-presenting cells
DE10161738B4 (en) * 2001-12-15 2006-12-07 Alexander Cherkasky Fusion proteins against T-cell tumors

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019163A1 (en) * 1992-03-18 1993-09-30 Yeda Research And Development Co, Ltd. Chimeric receptor genes and cells transformed therewith
US5359046A (en) * 1990-12-14 1994-10-25 Cell Genesys, Inc. Chimeric chains for receptor-associated signal transduction pathways
WO1996023814A1 (en) * 1995-02-03 1996-08-08 Cell Genesys, Inc. Chimeric receptor molecules for delivery of co-stimulatory signals

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359046A (en) * 1990-12-14 1994-10-25 Cell Genesys, Inc. Chimeric chains for receptor-associated signal transduction pathways
WO1993019163A1 (en) * 1992-03-18 1993-09-30 Yeda Research And Development Co, Ltd. Chimeric receptor genes and cells transformed therewith
WO1996023814A1 (en) * 1995-02-03 1996-08-08 Cell Genesys, Inc. Chimeric receptor molecules for delivery of co-stimulatory signals

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ABBAS,LICHTMAN,POBER: "Cellular and molecular immunology", 1994, W.B.SAUNDERS COMPANY, USA, XP002036287 *
GILLILAND ET AL.: "Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragments", TISSUE ANTIGENS, vol. 47, no. 1, January 1996 (1996-01-01), pages 1 - 20, XP002036286 *

Also Published As

Publication number Publication date
WO1997020048A2 (en) 1997-06-05

Similar Documents

Publication Publication Date Title
WO1998054225A3 (en) Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes
AU1704099A (en) Monoclonal human natural antibodies
AU6331296A (en) Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms, pharmaceutical compositions
NO980915L (en) Recombinant anti-CD4 antibody suitable for human therapy
AU5869596A (en) Anti-gp130 monoclonal antibodies
AU5665696A (en) Novel methods for the assay of troponin i and t and complexe s of troponin i and t and selection of antibodies for use in immunoassays
AU1332099A (en) Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use
AU4752696A (en) Monoclonal antibodies for human osteogenic cell surface antigens
AU1795901A (en) "bonzo" chemokine receptor antibodies and ligands
EP0842948A4 (en) ANTIFas LIGAND ANTIBODIES AND ASSAY METHOD BY USING THE SAME
AU3407197A (en) Purified sperm surface antigen, monoclonal antibody therefor and applications therefor
TR199600359A2 (en) Adhesion receptor antagonists.
WO1999020747A3 (en) HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS
WO1997020048A3 (en) Modified SFV molecules which mediate adhesion between cells and uses thereof
GB2307041B (en) Sheets,kits and methods for detecting antigens or antibodies
CA2193870A1 (en) Treponema Pallidum Fused Antigen and Assay for Anti-Treponema Pallidum Antibodies Using the Same Fused Antigen
WO1999065947A3 (en) Monoclonal antibodies directed against the g3bp protein, and uses
MX9606584A (en) Mass-sensitive biosensors.
AU4070500A (en) Assay kits and methods for immune complex-mediated activation involving shed antigens
AU6220096A (en) Method for the simultaneous detection of different antibodies and/or antigens
AU1971799A (en) Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients
AU2547995A (en) Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
AU2596397A (en) Monoclonal antibody that detects apoptotic antigen
HUP9601392A2 (en) Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor
WO1996040250A3 (en) Platelet-specific chimeric immunoglobulin and methods of use therefor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP MX

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97519211

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA